Excellent news, muzzarati Now let's hope BTA management announces this information in a way that doesn't drive the SP lower. LOLW (laugh out loud weeping)
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%